IT8848327A0 - SOLID ORAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF POTASSIUM AND MAGNESIUM DEFICIENCY AND METHOD FOR APPLYING IT - Google Patents

SOLID ORAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF POTASSIUM AND MAGNESIUM DEFICIENCY AND METHOD FOR APPLYING IT

Info

Publication number
IT8848327A0
IT8848327A0 IT8848327A IT4832788A IT8848327A0 IT 8848327 A0 IT8848327 A0 IT 8848327A0 IT 8848327 A IT8848327 A IT 8848327A IT 4832788 A IT4832788 A IT 4832788A IT 8848327 A0 IT8848327 A0 IT 8848327A0
Authority
IT
Italy
Prior art keywords
prophylaxis
potassium
applying
treatment
oral composition
Prior art date
Application number
IT8848327A
Other languages
Italian (it)
Other versions
IT1227010B (en
Inventor
Pravin B Sheth
Frederick J Dechow
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IT8848327A0 publication Critical patent/IT8848327A0/en
Application granted granted Critical
Publication of IT1227010B publication Critical patent/IT1227010B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT8848327A 1987-09-11 1988-09-08 SOLID ORAL COMPOSITION FOR THE CARE OR PROPHYLAXIS OF LACK OF POTASSIUM AND MAGNESIUM AND METHOD TO APPLY IT IT1227010B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9575087A 1987-09-11 1987-09-11

Publications (2)

Publication Number Publication Date
IT8848327A0 true IT8848327A0 (en) 1988-09-08
IT1227010B IT1227010B (en) 1991-03-05

Family

ID=22253423

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848327A IT1227010B (en) 1987-09-11 1988-09-08 SOLID ORAL COMPOSITION FOR THE CARE OR PROPHYLAXIS OF LACK OF POTASSIUM AND MAGNESIUM AND METHOD TO APPLY IT

Country Status (12)

Country Link
JP (1) JPH01100128A (en)
AU (1) AU619481B2 (en)
BE (1) BE1001842A3 (en)
CH (1) CH677612A5 (en)
DE (1) DE3830563A1 (en)
DK (1) DK501288A (en)
FR (1) FR2620334A1 (en)
GB (1) GB2209668B (en)
IT (1) IT1227010B (en)
LU (1) LU87331A1 (en)
NL (1) NL8802224A (en)
SE (1) SE8803125L (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0160454B1 (en) * 1989-06-20 1998-12-01 오오쓰까 아끼히꼬 Potassium-supplementing preparation
US5132118A (en) * 1990-05-11 1992-07-21 Mills John A Treatment of exercise-induced pulmonary hemorrhage in animals
FI911038A (en) * 1991-03-01 1992-09-02 Slk Marketing Oy DRYCKPULVER.
US5460972A (en) * 1991-04-08 1995-10-24 Research Foundation Of The State University Of New York Ionized magnesium2+ concentrations in biological samples
FR2677546B1 (en) * 1991-06-12 1994-01-21 Fabienne Joanny THERAPEUTIC COMPOSITION FOR EXTENDED RELEASE OF MAGNESIUM.
DE4201504C2 (en) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh magnesium preparation
CN1090483C (en) * 1997-07-31 2002-09-11 谢理峰 Potassium and magnesium controlled-release tablet and producing method thereof
DE10158286B4 (en) * 2000-11-20 2007-08-02 Dehn, Michael C. Active substance storage layer material
DE10126405A1 (en) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Pharmaceutical preparation containing physiologically compatible potassium and magnesium salts and its use for the prophylaxis and / or therapy of QT prolongations
ATE485814T1 (en) * 2005-08-19 2010-11-15 Verla Pharm MAGNESIUM DELAYED RELEASE MICRO TABLETS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA73467B (en) * 1972-02-25 1973-10-31 Hoffmann La Roche Mineral salts containing preparation
GB1422193A (en) * 1974-07-26 1976-01-21 Smith Kline French Lab Pharmaceutical compositions

Also Published As

Publication number Publication date
DK501288A (en) 1989-03-12
SE8803125D0 (en) 1988-09-06
CH677612A5 (en) 1991-06-14
AU619481B2 (en) 1992-01-30
DE3830563A1 (en) 1989-03-30
GB8821056D0 (en) 1988-10-05
FR2620334A1 (en) 1989-03-17
LU87331A1 (en) 1989-10-26
BE1001842A3 (en) 1990-03-20
IT1227010B (en) 1991-03-05
AU2204388A (en) 1989-03-16
SE8803125L (en) 1989-03-12
GB2209668B (en) 1991-06-05
JPH01100128A (en) 1989-04-18
GB2209668A (en) 1989-05-24
NL8802224A (en) 1989-04-03
DK501288D0 (en) 1988-09-09

Similar Documents

Publication Publication Date Title
EP0206529A3 (en) Treatment of oral diseases
NO982311D0 (en) Compositions and methods for the prevention and treatment of oral mucositis
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
IT8847858A0 (en) AGENTS FOR THE PROPHYLAXIS AND THERAPY OF RETROVIRAL INFECTIONS
BR9606778A (en) Cell adhesion inhibitors
MX171177B (en) COMPOSITION TO DISINFECT SUBSTRATES
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
DE3882775T2 (en) Composition for the treatment of periodontal disease.
IT8848327A0 (en) SOLID ORAL COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF POTASSIUM AND MAGNESIUM DEFICIENCY AND METHOD FOR APPLYING IT
BR9407743A (en) Oral composition of calcium peroxide-bicarbonate
IT1227072B (en) POTASSIUM CLAVULANATE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION
FI884195A0 (en) Deicing compositions containing substantially pure calcium magnesium acetate double salt and methods for their preparation
FR2612775B1 (en) COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SKIN DEGENERATION
IT1211791B (en) COMPOSITION OF SLOWLY RELEASED FLUORIDE FOR THE TREATMENT AND PREVENTION OF BONE DISEASES
IT8219482A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES.
GB8822546D0 (en) Antiviral combinations
HUT75528A (en) Use of dimeticone for treating aphthae and stomatitis
GR3006674T3 (en)
PH24723A (en) Device and composition for treatment of the gums
PT86292A (en) A process for the preparation of an antihypertensive pharmaceutical composition comprising a POTASSIUM CHANNEL ACTIVATOR (eg, CROMACALINE) AND AN ACE INHIBITOR (eg, ENALAPRIL)
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
MX164448B (en) ORAL COMPOSITION AGAINST CALCULATION FORMATION
IT1169978B (en) PREPARED FOR THE TREATMENT OF BURNS